MetaCap

Entrada Therapeutics Statistics

NASDAQ: TRDAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.35-0.29 (-6.25%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Entrada Therapeutics by the numbers

Entrada Therapeutics has a market capitalization of $170.3 million based on 39.15M shares outstanding. With trailing EPS of $-3.84, Entrada Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.1% below its 50-day average and 47.6% below its 200-day average.

Average daily trading volume is 401.15K shares, or about $1.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TRDA valuation vs. peer median

TRDA compared with the median of 8 peer companies
MetricTRDAPeer medianDifference
Market cap$170.30M$174.39M-2%
Avg. volume401.15K177.13K+126%

Peer median across 8 companies: SIGA, KRRO, ABEO, VOGX, NATR, EMIS, ADCT, SLGL.

Valuation

Market cap
$170.30M
Price / sales (latest FY)
6.70
EPS (TTM)
$-3.84

Price and trading

Previous close
4.64
Open
4.55
Day range
4.32 – 4.58
52-week range
4.11 – 16.45
52-week change
-56.97%
Beta
—
Volume
347.92K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
170.30M
Forward Pe
-1.27
Eps
-3.84
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
16.45
Week52 Low
4.11
Avg Volume
401.15K
Shares Outstanding
39.15M
Ma50
5.38
Ma200
8.30
Earnings Date
Nov 5, 2026
Pct From52w High
-73.56%
Pct From52w Low
5.87%

Related